These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25002632)

  • 21. European pharma consolidation generates quality spinoffs.
    Sheridan C
    Nat Biotechnol; 2006 Dec; 24(12):1458-9. PubMed ID: 17160029
    [No Abstract]   [Full Text] [Related]  

  • 22. Public vaccine manufacturing capacity in the Latin American and Caribbean region: current status and perspectives.
    Cortes Mde L; Cardoso D; Fitzgerald J; DiFabio JL
    Biologicals; 2012 Jan; 40(1):3-14. PubMed ID: 22033155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Science, money, and industry: is commerce corrupting AIDS research?
    Mirken B
    BETA; 2002; 15(2):40-4. PubMed ID: 12064305
    [No Abstract]   [Full Text] [Related]  

  • 24. Indian-born weapons for infectious diseases.
    Padmanaban G
    Nat Med; 2003 Jul; 9(7):813. PubMed ID: 12835687
    [No Abstract]   [Full Text] [Related]  

  • 25. Steve Carney talks to Vincent Lee on the pharma industry, the FDA and public education with respect to drugs and their development.
    Lee VH
    Drug Discov Today; 2005 Nov; 10(21):1411-4. PubMed ID: 16243258
    [No Abstract]   [Full Text] [Related]  

  • 26. Biotech's new colossus. Move over, Big Pharma. Amgen boasts better growth.
    Stipp D
    Fortune; 2002 Apr; 145(8):144-6, 148, 150. PubMed ID: 11961884
    [No Abstract]   [Full Text] [Related]  

  • 27. Can the pharmaceutical industry embrace comparative effectiveness research? A view from inside.
    Berger ML
    Expert Rev Pharmacoecon Outcomes Res; 2013 Oct; 13(5):565-8. PubMed ID: 24090045
    [No Abstract]   [Full Text] [Related]  

  • 28. AIDS vaccine duo.
    Nature; 2005 Jun; 435(7046):1159. PubMed ID: 15988492
    [No Abstract]   [Full Text] [Related]  

  • 29. Outsourcing to exploit a key asset.
    Meerpoel L; Schroven M; Goris K; Demoen K; Marsden S
    Drug Discov Today; 2006 Jun; 11(11-12):556-60. PubMed ID: 16713908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pharmaceutical industry--prices and progress.
    Scherer FM
    N Engl J Med; 2004 Aug; 351(9):927-32. PubMed ID: 15329432
    [No Abstract]   [Full Text] [Related]  

  • 31. GlaxoSmithKline, Pfizer to merge HIV drug units in new company.
    AIDS Read; 2009; 19(6):206. PubMed ID: 19642236
    [No Abstract]   [Full Text] [Related]  

  • 32. Cancer expert attacks drug company's funding of research paper.
    White C
    BMJ; 2007 Sep; 335(7618):469. PubMed ID: 17823164
    [No Abstract]   [Full Text] [Related]  

  • 33. Merck opts for shake-up to clear drug pipeline.
    Nature; 2005 Dec; 438(7071):1076-7. PubMed ID: 16371975
    [No Abstract]   [Full Text] [Related]  

  • 34. The patient-consumer-advocate nexus: the marketing and dissemination of gardasil, the human papillomavirus vaccine, in the United States.
    Gottlieb SD
    Med Anthropol Q; 2013 Sep; 27(3):330-47. PubMed ID: 24248992
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Productivity counts--but the definition is key.
    Mervis J
    Science; 2005 Jul; 309(5735):726. PubMed ID: 16051784
    [No Abstract]   [Full Text] [Related]  

  • 36. The winning shot. New vaccine technologies to offer pinpoint attacks on a variety of potentially deadly diseases.
    Kirchheimer B
    Mod Healthc; 2005 Nov; 35(46):52-4. PubMed ID: 16334833
    [No Abstract]   [Full Text] [Related]  

  • 37. The costs and economics of modern vaccine development.
    Batson A
    Dev Biol (Basel); 2002; 110():15-24. PubMed ID: 12477302
    [No Abstract]   [Full Text] [Related]  

  • 38. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 39. [Commercialization of the medical research is a reality. What is the limit?].
    Naeser K
    Ugeskr Laeger; 2005 Oct; 167(43):4103; author reply 4103-5. PubMed ID: 16251105
    [No Abstract]   [Full Text] [Related]  

  • 40. Financial Times Global Pharmaceutical & Biotechnology Conference 2009.
    Scattereggia J
    IDrugs; 2010 Jan; 13(1):26-9. PubMed ID: 20024844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.